Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4888955

N.c1ccc(-c2ccc3c(c2)CC3)cc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 2/20 0.50
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 2/20 0.48
TDP2 O95551 1/20 0.47
PARP10 Q53GL7 1/20 0.46
PARP11 Q9NR21 1/20 0.46
TYRO3 Q06418 1/20 0.44
NTRK2 Q16620 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
DYRK1B Q9Y463 1/20 0.44
ALDH1A1 P00352 2/20 0.43
ALOX5 P09917 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6253369 0.98 HSD17B3 (0.51) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL21028472 0.93 HSD17B3 (0.49) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL27445644 0.88 CYP11B1 (0.56) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL9845507 0.88 CYP11B1 (0.61) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL30125264 0.88 CYP11B1 (0.56) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL20079881 0.85 CYP11B1 (0.52) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL14618924 0.82 TDP2 (0.46) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL14618928 0.82 TDP2 (0.46) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL4970944 0.80 CYP1A2 (0.67) HSD17B3CYP11B1CYP11B2TDP2PARP10
SCHEMBL27806355 0.80 CYP2A6 (0.59) HSD17B3CYP11B1CYP11B2TDP2PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214845-A1 ANTIBACTERIAL 6'-MODIFIED 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2008-09-04 US disclosed
WO-2007028012-A2 ANTIBACTERIAL 6'-N-MODIFIED 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214845-A1 ANTIBACTERIAL 6'-MODIFIED 4,5-SUBSTITUTED AMINOGLYCOSIDE ANALOGS FUT6, ALG8, NRDC HSD17B3 4746/4885CYP11B1 4490/4885CYP11B2 4460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.